1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione(376382-11-5)
- Name: 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
- Synonyms:HMS1493I11;
- Molecular Formula:C24H18N2O2
- Molecular Weight:366.41
- CAS Registry Number:376382-11-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.376382-11-5 BRD 7389
Assay:98%Min Appearance:detailed in specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by ocean shipping Application:An important raw material and intermediate used in Organic Synthesis, Pharmaceuticals
Min. Order:0
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.376382-11-5 1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.376382-11-5 BRD7389;376382-11-5
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal ChemistryBiomedicinePharmaceutical intermediatesChemistry experimentBiological experimentsChemical reagentFor R&D use only.
Min. Order:10Metric Ton
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.376382-11-5 BRD 7389
Assay:鈮?7% by HPLC Package:inquiry Transportation:inquiry Application:BRD 7389 is a ribosomal S6 kinase (RSK) inhibitor (IC50 = 1.2, 1.5 and 2.4 渭M for RSK3, RSK1 and RSK2, respectively). It upregulates insulin expression in mouse 伪TC1 pancreatic 伪 cells.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 887702-61-6/1H-Pyrazole-5-heptanoic acid, 1-(4-fluorophenyl)-b,d-dihydroxy-4-(1-methylethyl)-3-[[[(4-methylphenyl)methyl]amino]carbonyl]-, sodium salt (1:1), (bR,dR)-
- 887701-48-6/1H-Pyrazole-5-heptanoic acid, 1-(4-fluorophenyl)-b,d-dihydroxy-4-(1-methylethyl)-3-[[[(4-methylphenyl)methyl]amino]carbonyl]-, (bR,dR)-
- 724444-40-0/Ethanediamide, N1-[(10S)-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-4,6,7,8,9,10-hexahydro-3-hydroxy-4-oxopyrimido[1,2-a]azepin-10-yl]-N1,N2,N2-trimethyl-
- 226878-01-9/NPS 2390
- 440124-11-8/2-Pyrazinecarbonitrile, 6-ethyl-5-methyl-3-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-
- 209957-47-1/1H-Pyrazole-5-carboxamide, 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-
- 1003711-55-4/2-Chloro-5-methoxy-3-nitropyridine
- 401647-22-1/N-METHYL-(3-METHYLISOXAZOL-5-YLMETHYL)AMINE
- 1223001-51-1/9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one
- 934541-31-8/5-[3-(Ethylsulfonyl)phenyl]-3,8-dimethyl-N-(1-methyl-4-piperidinyl)-9H-pyrido[2,3-b]indole-7-carboxamide
- 945493-87-8/GSK 189254
- 575467-49-1/2-Propen-1-one, 1-[(2S)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinyl]-3-[4-(trifluoromethyl)phenyl]-, hydrochloride (1:1), (2E)-
- 575467-47-9/(2E)-1-[(2S)-2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]-3-[4-(trifluoromethyl)phenyl]prop-2-en-1-one
- 461045-17-0/A 423579
- 392338-13-5/A 331440
- 910378-55-1/Butanoic acid, 2-[3-[3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]phenoxy]-, hydrate (1:2), (2R)-
- 668458-85-3/Butanoic acid, 2-[3-[3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]phenoxy]-, sodium salt (1:1), (2R)-
- 668455-28-5/Butanoic acid, 2-[3-[3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]phenoxy]-, (2R)-
- 120964-45-6/3-Cyclopentene-1,2-diol, 5-(4-aMino-1H-iMidazo[4,5-c]pyridin-1-yl)-3-(hydroxyMethyl)-, (Hydrochloride) (1:1), (1S,2R,5R)-
- 376382-11-5/1-[(2-Phenylethyl)amino]-3H-naphtho[1,2,3-de]quinoline-2,7-dione
- 211230-67-0/ONO AE 248
- 216158-34-8/ONO-8711
- 253350-43-5/AE 1-329
- 1166977-17-8/1H-Imidazole-5-methanamine, 1-[(3-amino[1,1'-biphenyl]-4-yl)methyl]-N-[6-(2-benzothiazolyl)[1,1'-biphenyl]-3-yl]-
- 1166977-14-5/1H-Imidazole-5-methanamine, 1-[(3-amino[1,1'-biphenyl]-4-yl)methyl]-N-(6-chloro[1,1'-biphenyl]-3-yl)-
- 304025-53-4/Acetamide, N-[2-[3,4-dihydro-7-[[[(3R,4R)-4-[4-[3-[(2-methoxyphenyl)methoxy]propoxy]phenyl]-3-piperidinyl]oxy]methyl]-1(2H)-quinolinyl]ethyl]-
- 1041439-02-4/3,9-Diazabicyclo[3.3.1]non-6-ene-6-carboxamide, N-cyclopropyl-7-[4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl]-N-[(2,3-dimethylphenyl)methyl]-, (1R,5S)-, methanesulfonate (1:2)
- 903579-36-2/3,9-Diazabicyclo[3.3.1]non-6-ene-6-carboxamide, N-cyclopropyl-7-[4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl]-N-[(2,3-dimethylphenyl)methyl]-, (1R,5S)-
- 1160849-72-8/L-Phenylalanine, N-(2-chloro-6-methylbenzoyl)-4-[[(3,5-dichloro-4-pyridinyl)carbonyl]amino]-
- 1061747-72-5/Acetamide, N-[2-(3,5-dimethyl-1H-pyrazol-1-yl)-6-[6-(4-methoxy-1-piperidinyl)-2-pyridinyl]-4-pyrimidinyl]-